Ortivus

1.22 SEK

0.00 %

Less than 1K followers

ORTI B

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

0.00 %

0.00 %

+7.02 %

-18.12 %

-12.23 %

-25.84 %

-77.07 %

-75.55 %

-98.97 %

Ortivus is engaged in the health care sector. The company specializes in the development of mobile solutions. The services include, for example, monitoring and communication solutions that are further used in decision-making and support systems. Today, the solutions are resold under various brands. The largest business operations are held in the Nordic region, and Europe. Ortivus was established in 1985 and is headquartered in Danderyd.

Market cap

108.11M SEK

Turnover

717.63K SEK

Revenue

80.41M

EBIT %

-24.29 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

20.2

2026

Annual report '25

All

Press releases

ShowingAll content types

Regulatory press release12/2/2025, 7:53 AM

Ortivus announces mandatory public offer from Ponderus Invest AB

Regulatory press release11/28/2025, 7:30 AM

Interim Report for Ortivus AB (publ) for the period July – September 2025

Regulatory press release11/14/2025, 2:30 PM

ORTIVUS INFORMS ABOUT A POSSIBLE MANDATORY BID FROM PONDERUS INVEST

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release10/15/2025, 6:35 AM

Ortivus announces that CFO Johan Wewel has decided to leave his position

Regulatory press release10/9/2025, 2:00 PM

All conditions for the Subscription Guarantee in Ortivus AB’s ongoing Rights Issue now fulfilled

Press release10/7/2025, 7:15 AM

Ortivus presents its operations and future market opportunities

Regulatory press release9/30/2025, 7:45 AM

Ortivus publishes information document regarding Rights Issue of shares

Press release9/25/2025, 6:30 AM

First day of trading in Ortivus' shares without the right to obtain subscription rights regarding the share issue

Press release9/24/2025, 11:15 AM

Last day for trading in Ortivus's shares including the right to participate in the share issue

Regulatory press release9/19/2025, 2:10 PM

Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue

Regulatory press release9/9/2025, 6:30 AM

Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility

Regulatory press release8/26/2025, 8:15 AM

Ortivus’ Main Shareholder Ponderus Invest AB Extends Credit Facility Agreement with Ortivus

Press release7/25/2025, 12:45 PM

Ortivus Secures Two-Year Contract Extension with South Central Ambulance Service (SCAS)

Press release6/17/2025, 6:30 AM

Ortivus secures two-year contract extension with South Western Ambulance Service (SWASFT)

Regulatory press release6/9/2025, 6:00 AM

Ortivus reaches agreement on the termination of the project with the Estonian Health Insurance Fund

Press release5/26/2025, 1:45 PM

Ortivus receives two-year contract extension from Northern Ireland Ambulance Service (NIAS)

Regulatory press release5/9/2025, 6:35 AM

Correction: Interim Report for Ortivus AB (publ) for the period January - March 2025

Regulatory press release5/8/2025, 6:30 AM

Interim Report for Ortivus AB (publ) for the period January - March 2025

Regulatory press release4/11/2025, 8:35 AM

Correction: The Board of Directors of Ortivus AB withdraws the proposal to the Annual General Meeting on 8 May 2025 regarding authorisation for the Board to issue shares, etc.

Press release3/11/2025, 3:00 PM

We are pleased to welcome two new colleagues to Ortivus!

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.